Keyphrases
Acute Lymphoblastic Leukemia
32%
Alglucerase
11%
Ashkenazi Jews
11%
B Cells
11%
Bone Crisis
24%
Bone Marrow
18%
Brain Tumor
14%
Central Nervous System
13%
Chemotherapy
30%
Childhood Acute Lymphoblastic Leukemia
32%
Clinical Significance
10%
Enzyme Replacement Therapy
22%
Event-free Survival
12%
Ewing Sarcoma
68%
Ewing Sarcoma Family of Tumors
29%
Folinic Acid
44%
Gaucher Disease
100%
Germ Cells
17%
Glioma
11%
High Dose
23%
High Risk
13%
High-dose Methotrexate (HD-MTX)
36%
Ifosfamide
10%
Improved Outcomes
12%
Israel
22%
Leukemia
15%
Leukemic Cells
13%
Loss of Heterozygosity
10%
Medulloblastoma
13%
Methotrexate
40%
N370S
10%
Natural History
12%
Neurotoxicity
31%
Osteosarcoma
13%
P53 Gene
18%
Partial Splenectomy
11%
Pediatric
13%
Platelets
10%
Poor Prognosis
10%
Radiotherapy
13%
Rewarming
17%
T Cells
10%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
12%
Thrombocytopenia
18%
TP53 mutation
21%
Treatment Protocol
18%
Tumor
57%
Tumor Cells
13%
Visual Pathway
11%
Working Diagnosis
29%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
27%
Alglucerase
13%
B Cell
8%
Bone Scintigraphy
10%
Brainstem
7%
Central Nervous System
17%
Childhood Cancer
8%
Cold Injury
7%
Connective Tissue Cancer
9%
Diseases
41%
Doxorubicin
8%
Drug Megadose
34%
Enzyme Replacement Therapy
23%
Event Free Survival
8%
Ewing Family of Tumors
13%
Ewing Sarcoma
50%
Folinic Acid
25%
Ganglioglioma
24%
Gaucher Disease Type 1
31%
Gaucher's Disease
49%
Hepatoblastoma
7%
Hodgkin's Lymphoma
9%
Idiopathic Thrombocytopenic Purpura
7%
Imiglucerase
7%
Infancy
7%
Intracranial Tumor
18%
Leukemia
14%
Limb
11%
Low Drug Dose
10%
Lymphocyte
8%
Magnetic Resonance Imaging
13%
Medulloblastoma
7%
Methotrexate
38%
Neoplasm
55%
Neurofibromatosis
7%
Neurotoxicity
18%
Osteosarcoma
16%
Pediatrics
27%
Peripheral Blood Stem Cell
8%
Platelet
19%
Prematurity
7%
Primary Tumor
9%
Protein P53
7%
Radiation Therapy
14%
Recurrent Disease
9%
Splenectomy
11%
Thrombocytopenia
15%
Tumor Cell
13%
Vincristine Sulfate
7%
Visual Pathway
11%